查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623659

基因分型检测市场评估:按产品、技术、应用、最终用户和地区划分的机会和预测（2018-2032 年）

Genotyping Assay Market Assessment, By Products, By Technology, By Application By End-user, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 232 Pages | 商品交期: 3-5个工作天内

价格

全球基因分型检测市场规模预计将从 2024 年的 209.9 亿美元增长到 2032 年的 635.4 亿美元，预测期内的复合年增长率为 14.85%。

由于遗传疾病和慢性病发病率的上升以及基因组技术的进步，预计基因分型检测的市场需求将在未来几年呈指数级增长。

基因分型分析是实验室透过分析 DNA 来确定身体基因组成（基因型）的一种方法。在基因组的特定位置可以识别出遗传变异，例如单一核甘酸多重单核甘酸多态性 (SNP)、插入、缺失和其他突变。由于遗传疾病的盛行率不断上升、精准医疗以及个人化医疗解决方案的需求不断增长，基因分析市场正在经历显着增长。下一代微晶片测序（NGS）、聚合酶炼式反应（PCR）以及准确有效的基因分析等先进技术的广泛应用推动了市场的发展。

主要参与者正专注于产品创新、策略合作以及药物基因组学、肿瘤学和传染病诊断等领域的应用扩展，以推动市场成长。

本报告调查了全球基因分型检测市场，并提供了市场定义和概述、市场规模趋势和预测、各个细分市场、地区和主要国家的详细分析、行业结构、影响市场增长的因素分析、案例研究、竞争格局和主要公司的概况。

目录

第 1 章 专案范围与定义

第 2 章 研究方法

第 3 章执行摘要

第 4 章全球基因分型检测市场展望

  • 市场规模分析及预测
  • 市占率分析及预测
    • 按产品
    • 按技术
    • 依用途
    • 按最终用户
    • 按地区
    • 公司占有率分析（前 5 名及其他）
  • 市场地图分析

第 5 章北美基因分型检测市场展望

  • 市场规模分析及预测
  • 市占率分析及预测
  • 国家市场评估
    • 美国
    • 加拿大
    • 墨西哥

第6章 欧洲基因分型检测市场展望

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙 火鸡
  • 波兰

第7章亚太地区基因分型检测市场展望

  • 印度
  • 中国
  • 日本
  • 澳大利亚 越南
  • 韩国
  • 印尼
  • 菲律宾

第 8 章南美洲基因分型检测市场展望

  • 巴西
  • 阿根廷

第 9 章：中东与非洲基因分型检测市场展望

  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第 10 章 供需分析

第 11 章 价值链分析

第 12 章 波特五力分析

第 13 章 PESTLE 分析

第 14 章 定价分析

第 15 章 市场动态

  • 市场推动因素
  • 市场课题

第 16 章 市场趋势与发展

第 17 章 监理架构与创新

  • 临床试验
  • 监理机关核准

第 18 章：专利格局

第 19 章案例研究

第 20 章 竞争格局

  • 前 5 个竞争矩阵
  • 前 5 家公司的 SWOT 分析
  • 前 8 家公司的状况
      赛默飞世尔科技公司 Eurofins Scientific Inc.
    • F. 霍夫曼-拉罗氏公司 Bio-Rad 实验室公司 GE医疗集团 Illumina 公司 QIAGEN N.V. 丹纳赫公司

第 21 章 策略建议

第22章 关于我们/免责声明

Product Code: MX12497

Global genotyping assay market is projected to witness a CAGR of 14.85% during the forecast period 2025-2032, growing from USD 20.99 billion in 2024 to USD 63.54 billion in 2032. The market demand for genotyping assays is anticipated to thrive drastically in the forecast years due to the rising prevalence of genetic disorders, chronic diseases, and technological advancements in genomic technologies.

Genotyping analysis is a method used in the laboratory to determine the body's genetic composition (genetic type) by analyzing the DNA. In a specific place of the genome, genetic mutations are identified, such as individual nucleotide multiple type single nucleotide polymorphisms (SNPs), insertions, deletions, or other mutations. The genetic analysis market grows significantly due to an increase in the rate of genetic disorders, the accurate medical field, and the growing demand for personalized healthcare solutions. The market is promoted by the extensive introduction of advanced technology, such as the next-generation microchip sequence (NGS), the polymerase chain reaction (PCR), and the analysis of accurate and effective genetic analysis. Leading companies are focusing on product innovation, strategic alliances, and application expansion in areas such as pharmacogenomics, oncology, infectious disease diagnostics, etc., driving the market growth. For instance, in October 2024, LGC Biosearch Technologies Limited launched Amp-Seq One, a revolutionary one-step amplicon sequencing workflow for commercial breeding. With a 120-minute turnaround time and no liquid handling equipment needed, it minimizes hands-on time, reduces consumables, lowers contamination risks, doubles throughput, and delivers unmatched speed and precision in agricultural genomics.

Increasing Prevalence of Genetic Disorders

The growing incidence of genetic diseases is a significant growth factor for the global genotyping assay market. Increasing cases of cancer, cystic fibrosis, sickle cell anemia, and cardiovascular diseases necessitate early and accurate diagnostic tools. Genotyping assays can accurately identify the genetic mutations to allow early intervention and targeted therapy. There is now increased awareness about hereditary and somatic mutations, further increasing demand for genotyping in clinical as well as research areas. Awareness about genetic testing is also increased by both healthcare providers and patients with the implementation of genetic diagnostics in routine medical care, the adoption of genotyping assays market growth in the forecast period. For instance, in October 2024, Revvity, Inc. announced the launch of the in-vitro diagnostic EURORealTime APOE assay in CE-marked European countries. This assay enables precise apolipoprotein E (APOE) gene genotyping to assess Alzheimer's patients' risk for adverse side effects from anti-amyloid therapies, which is crucial for personalized treatment plans and managing potential amyloid-related imaging abnormalities-related risks.

Advancements in Genotyping Technologies

Advancement in genotyping technologies is poised to witness significant growth in the genotyping market; the increasing prevalence of genetic disorders is fueling the demand for accurate and efficient genotyping methods, particularly in the field of personalized medicine and drug development. Advanced technologies such as next-generation sequencing and polymerase revolutionized genetic analysis that guarantees quick and accurate detection of genetic fluctuations in various uses. These technological innovations enhance the effectiveness of genotyping analysis, reduce costs, and make it more affordable for researchers and medical workers. Additionally, increasing collaborations between academic institutions and biotech companies are helping to create an environment conducive to innovation, thereby expanding market growth. For instance, in June 2024, MGI Tech Co., Ltd. announced a new automated workflow for large-scale Low-pass Whole Genome Sequencing (WGS) Solutions for Agriculture. The solution streamlines molecular breeding with tools for extraction, library prep, sequencing, and SNP/InDel calling. The MGIEasy Large-scale polymerase chain reaction Free FS Library Prep Set simplifies library construction with a plate-based design, cutting steps, time, and consumables.

Reagents and Kits Segment to Dominate the Genotyping Assay Market

The reagents and kits segment is anticipated to dominate the genotyping assay market primarily because of its role in ensuring accurate results, as well as reproducible results, across various genotyping applications. The segment further benefits from the increasing adoption of ready-to-use kits, which simplify the workflow and reduce procedural errors in research and clinical settings. Due to the increasing demand for high-throughput genotyping, innovations in reagent formulation for technologies like next-generation sequencing and polymerase chain reaction and microarrays enhance the segment's growth prospects. Additionally, this contributes to a continuous flow of revenue, making the segment fuel the market growth. For instance, in June 2024, Omixon Inc. launched HoloGRAFT ONE, a simplified digital polymerase chain reaction kit for monitoring donor-derived cell-free DNA (dd-cfDNA) in transplant research. Its single-use, dry reagent format eliminates handling errors and streamlines workflows. The assay offers direct, absolute quantification of donor-specific genetic markers for improved transplant monitoring.

North America Dominates Genotyping Assay Market

The overall market for genotyping assays worldwide is dominated by North America, due to the excellent infrastructural facilities for healthcare available here, high research and development activity, and extensive adoption of advanced genomic technologies. Notable biotechnology and pharmaceutical firms, as well as huge government spending on genomics research, make further enhancements in the market. The increasing incidence of chronic diseases, personalized medicine initiatives, and the increasing demand for precision diagnostics have created a strong demand for genotyping assays in the region. For instance, in May 2024, F. Hoffmann-La Roche AG launched an HPV self-collection solution that received FDA approval, offering an accessible screening option. Individuals can collect vaginal samples in a healthcare setting, then analyze them using Roche's Cobas molecular instrument. Positive results lead to further care with a healthcare provider, enabling early detection of cervical cancer risks.

Future Market Scenario (2025-2032F)

The future market scenario for the global genotyping assay market looks very promising, as rapid advancement in genomic technologies and the adoption of precision medicine are driving this market. Emerging trends such as artificial intelligence and machine learning integration in genomic data analysis are expected to streamline workflows and enhance diagnostic accuracy. The increasing incidence of genetic diseases, along with the increased demand for pharmacogenomics and personalized medicines, will fuel further growth in the market. In addition, the increased focus on agricultural genomics and animal breeding is expected to create new growth opportunities. Increased access to cost-effective, high-throughput genotyping platforms is sustainable growth in the market. For instance, in March 2024, Nucleus Genomics, Inc. launched DNA analysis and whole genome sequencing services for personalized genetic risk and health reports. Customers can upload existing microarray DNA data to gain insights into diseases like type 2 diabetes and breast cancer, with analysis incorporating lifestyle factors like age, body mass index, and cholesterol.

Key Players Landscape and Outlook

The genotyping assay market is characterized by its dynamic landscape, shaped by the actions of numerous key players, including significant business agreements and regulatory approvals for various products. The sector experienced a surge in strategic initiatives, encompassing mergers, acquisitions, and collaborations, reflecting a robust drive for innovation and growth within the industry.

For instance, in January 2024, Thermo Fisher Scientific Inc. launched Axiom PangenomiX Array, its most comprehensive and ethnically diverse array of genetic research. Designed for large-scale disease studies and pharmacogenomic research, this array offers optimal genetic coverage based on the pangenome, a more inclusive representation of human genomic variation. This launch supports the shift toward proactive healthcare and personalized medicine, focusing on the genetic basis of disease risk and drug responses.

For instance, in September 2024, Integrated DNA Technologies, Inc. launched Archer HRD Technology for comprehensive genomic profiling solutions with the addition of homologous recombination deficiency assessment. This new technology is available as a standalone assay, a supplementary module, or integrated into Archer's existing NGS panels, offering customizable solutions for cancer research labs.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Genotyping Assay Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Instruments
      • 4.2.1.2. Software and Services
      • 4.2.1.3. Reagents and Kits
    • 4.2.2. By Technology
      • 4.2.2.1. Polymerase Chain Reaction
      • 4.2.2.2. Capillary Electrophoresis
      • 4.2.2.3. Sequencing
      • 4.2.2.4. Microarrays
      • 4.2.2.5. Mass Spectrometry
      • 4.2.2.6. Others
    • 4.2.3. By Application
      • 4.2.3.1. Pharmacogenomics
      • 4.2.3.2. Agriculture Biotechnology
      • 4.2.3.3. Animal Genetics
      • 4.2.3.4. Diagnostics and Personalized Medicine
      • 4.2.3.5. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Pharmaceutical and Biopharmaceutical Companies
      • 4.2.4.2. Diagnostics and Research Laboratories
      • 4.2.4.3. Academics Institutes
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product
    • 4.3.2. By Technology
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Genotyping Assay Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Instruments
      • 5.2.1.2. Software and Services
      • 5.2.1.3. Reagents and Kits
    • 5.2.2. By Technology
      • 5.2.2.1. Polymerase Chain Reaction
      • 5.2.2.2. Capillary Electrophoresis
      • 5.2.2.3. Sequencing
      • 5.2.2.4. Microarrays
      • 5.2.2.5. Mass Spectrometry
      • 5.2.2.6. Others
    • 5.2.3. By Application
      • 5.2.3.1. Pharmacogenomics
      • 5.2.3.2. Agriculture Biotechnology
      • 5.2.3.3. Animal Genetics
      • 5.2.3.4. Diagnostics and Personalized Medicine
      • 5.2.3.5. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Pharmaceutical and Biopharmaceutical Companies
      • 5.2.4.2. Diagnostics and Research Laboratories
      • 5.2.4.3. Academics Institutes
      • 5.2.4.4. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Genotyping Assay Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Instruments
          • 5.3.1.2.1.2. Software and Services
          • 5.3.1.2.1.3. Reagents and Kits
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Polymerase Chain Reaction
          • 5.3.1.2.2.2. Capillary Electrophoresis
          • 5.3.1.2.2.3. Sequencing
          • 5.3.1.2.2.4. Microarrays
          • 5.3.1.2.2.5. Mass Spectrometry
          • 5.3.1.2.2.6. Others
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Pharmacogenomics
          • 5.3.1.2.3.2. Agriculture Biotechnology
          • 5.3.1.2.3.3. Animal Genetics
          • 5.3.1.2.3.4. Diagnostics and Personalized Medicine
          • 5.3.1.2.3.5. Others
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Pharmaceutical and Biopharmaceutical Companies
          • 5.3.1.2.4.2. Diagnostics and Research Laboratories
          • 5.3.1.2.4.3. Academics Institutes
          • 5.3.1.2.4.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Genotyping Assay Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Genotyping Assay Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Genotyping Assay Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Genotyping Assay Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Regulatory Approvals
  • 17.2. Clinical Trials

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 8 Market Players
    • 20.3.1. Thermo Fisher Scientific Inc.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 20.3.2. Eurofins Scientific Inc.
    • 20.3.3. F. Hoffmann-La Roche AG
    • 20.3.4. Bio-Rad Laboratories Inc.
    • 20.3.5. GE Healthcare Inc.
    • 20.3.6. Illumina Inc.
    • 20.3.7. QIAGEN N.V.
    • 20.3.8. Danaher Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 3. Global Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 4. Global Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 5. Global Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Genotyping Assay Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 9. North America Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 10. North America Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 11. North America Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 12. North America Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 15. United States Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 16. United States Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 17. United States Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 18. Canada Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 20. Canada Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 21. Canada Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 22. Canada Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 23. Mexico Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 25. Mexico Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 26. Mexico Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 27. Mexico Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 28. Europe Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 30. Europe Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 31. Europe Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 32. Europe Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 33. Europe Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 36. Germany Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 37. Germany Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 38. Germany Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 39. France Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 41. France Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 42. France Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 43. France Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 44. Italy Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 46. Italy Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 47. Italy Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 48. Italy Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 49. United Kingdom Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 51. United Kingdom Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 52. United Kingdom Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 53. United Kingdom Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 54. Russia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 56. Russia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 57. Russia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 58. Russia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 59. Netherlands Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 61. Netherlands Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 62. Netherlands Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 63. Netherlands Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 64. Spain Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 66. Spain Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 67. Spain Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 68. Spain Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 69. Turkey Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 71. Turkey Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 72. Turkey Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 73. Turkey Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 74. Poland Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 76. Poland Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 77. Poland Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 78. Poland Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 79. South America Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 81. South America Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 82. South America Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 83. South America Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 84. South America Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 87. Brazil Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 88. Brazil Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 89. Brazil Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 90. Argentina Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 92. Argentina Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 93. Argentina Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 94. Argentina Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 95. Asia-Pacific Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 97. Asia-Pacific Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 98. Asia-Pacific Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 99. Asia-Pacific Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 100. Asia-Pacific Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 101. India Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 103. India Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 104. India Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 105. India Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 106. China Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 108. China Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 109. China Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 110. China Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 111. Japan Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 113. Japan Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 114. Japan Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 115. Japan Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 116. Australia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 118. Australia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 119. Australia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 120. Australia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 121. Vietnam Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 123. Vietnam Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 124. Vietnam Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 125. Vietnam Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 126. South Korea Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 128. South Korea Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 129. South Korea Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 130. South Korea Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 131. Indonesia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 133. Indonesia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 134. Indonesia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 135. Indonesia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 136. Philippines Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 138. Philippines Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 139. Philippines Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 140. Philippines Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 141. Middle East & Africa Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 143. Middle East & Africa Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 144. Middle East & Africa Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 145. Middle East & Africa Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 146. Middle East & Africa Genotyping Assay Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 149. Saudi Arabia Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 150. Saudi Arabia Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 151. Saudi Arabia Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 152. UAE Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 154. UAE Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 155. UAE Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 156. UAE Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 157. South Africa Genotyping Assay Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Genotyping Assay Market Share (%), By Products, 2018-2032F
  • Figure 159. South Africa Genotyping Assay Market Share (%), By Technology, 2018-2032F
  • Figure 160. South Africa Genotyping Assay Market Share (%), By Application, 2018-2032F
  • Figure 161. South Africa Genotyping Assay Market Share (%), By End-user, 2018-2032F
  • Figure 162. By Products Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024